Depression, Anxiety and Stress Scales DASS-21

1. Abstract

The Depression, Anxiety and Stress Scales (DASS-21) is a widely utilized, psychometrically validated, 21-item self-report instrument designed to quantify the severity of the core negative emotional dimensions of depression, anxiety, and tension/stress. Developed by Syd H. Lovibond and Peter F. Lovibond in 1995 as a streamlined short-form variant of the original 42-item DASS, the instrument isolates distinct affective states while retaining continuous measurement of psychological distress. The depression subscale focuses primarily on dysphoric mood, anhedonia, devaluation of life, self-deprecation, and lack of incentive. The anxiety scale targets autonomic nervous system arousal, skeletal musculature reactivity, situational panic, and the subjective perception of anxious affect. The stress scale measures non-specific chronic arousal, difficulty winding down, nervous exhaustion, irritability, impatience, and generalized hyperarousal.

Each of the three subscales comprises seven items evaluated on a 4-point Likert-type severity-frequency rating scale spanning from 0 ("Did not apply to me at all") to 3 ("Applied to me very much or most of the time"), reflecting symptom experience over the preceding seven days. Scores for each subscale are typically multiplied by two to map onto the normative ranges and clinical severity cutoffs established for the full-length 42-item instrument. Extensive structural equation modeling, exploratory factor analysis, and confirmatory factor analysis across non-clinical, clinical, and diverse cultural populations provide empirical corroboration for a tripartite or bifactor structural architecture. The DASS-21 demonstrates high internal consistency, with Cronbach's alpha coefficients routinely exceeding .88 for Depression, .82 for Anxiety, and .90 for Stress, alongside robust convergent validity when compared against the Beck Depression Inventory (BDI) and the Beck Anxiety Inventory (BAI).

2. Keywords

DASS-21, Depression Anxiety Stress Scales, psychometrics, affective disorders, structural equation modeling, tripartite model, internal consistency, construct validity, psychological assessment, negative affectivity, psychopathology, self-report inventory

3. Authors

The Depression, Anxiety and Stress Scales were conceptualized, standardized, and published by:

• Peter F. Lovibond, Ph.D. — School of Psychology, University of New South Wales (UNSW Sydney), Sydney, New South Wales, Australia. Clinical psychologist and academic researcher specializing in human associative learning, conditioning, anxiety disorders, and psychometrics.
• Sydney H. Lovibond, Ph.D. (1924–2010) — Emeritus Professor, School of Psychology, University of New South Wales (UNSW Sydney), Sydney, Australia. Pioneer in clinical behavioral psychology and measurement paradigms for emotional distress.

Institutional Origin: The instrument was formally developed, standardized, and normed within the School of Psychology at the University of New South Wales, Sydney, Australia.

4. Purpose

The primary clinical and empirical purpose of the Depression, Anxiety and Stress Scales (DASS-21) is to provide a reliable, dimensional assessment of emotional distress that maximizes discriminative validity among three interrelated yet distinct affective conditions: depression, anxiety, and psychological stress. For decades, clinical assessment protocols encountered significant empirical overlap when distinguishing between clinical depression and generalized anxiety states. Existing instruments such as the Beck Depression Inventory (BDI) and the State-Trait Anxiety Inventory (STAI) frequently exhibited high mutual correlations (.60 to .75), largely attributable to shared variance in general negative affectivity, neuroticism, or general psychological distress, as outlined in the tripartite model of anxiety and depression.

To overcome this diagnostic and psychometric dilemma, the Lovibonds pursued an iterative empirical development strategy. Rather than defining items based exclusively on historical diagnostic categories such as those in the Diagnostic and Statistical Manual of Mental Disorders (DSM), the authors established item pools characterizing the prototypical affective manifestations of clinical depression and physiological anxiety. During this process, factor analytic procedures consistently identified a third distinct, coherent factor that could not be subsumed under either classic depressive dysphoria or somatic/autonomic anxiety: a state of persistent, non-specific nervous tension, impatience, and difficulty relaxing, designated as "Stress."

The DASS-21 serves multifaceted functions across clinical, psychiatric, epidemiological, and research contexts:

• Screening and Severity Grading: While the DASS-21 is not a standalone categorical diagnostic interview, it serves as an efficient dimensional screening measure to quantify symptom severity across normal, mild, moderate, severe, and extremely severe ranges.
• Treatment Outcome Monitoring: Because the DASS-21 adopts a 7-day recall frame and exhibits substantial sensitivity to therapeutic change, clinicians utilize it longitudinally to assess responses to cognitive-behavioral therapy (CBT), psychopharmacological regimens, and other clinical interventions.
• Theoretical and Psychometric Research: The scale enables investigators to examine the etiology, maintenance mechanisms, and cognitive-affective profiles of distinct mood and emotional disorders without conflating somatic tension with autonomic panic or anhedonic apathy.

5. Psychological Construct

The DASS-21 operationalizes three primary psychological constructs, each measured via seven targeted indicators reflecting the core cognitive, physiological, and behavioral components of the respective affective condition.

Depression Subscale

The DASS-21 Depression subscale conceptualizes depression primarily as a state characterized by anhedonia, loss of self-worth, despair, and inertia. Rather than loading items with general somatic complaints that overlap with medical conditions or generalized fatigue, the subscale specifically operationalizes:

• Anhedonia and Positive Affect Deficits: The inability to experience pleasure, positive valence, or enthusiasm (e.g., Item 3: "I couldn't seem to experience any positive feeling at all"; Item 16: "I was unable to become enthusiastic about anything").
• Avolition and Impaired Initiative: Profound lethargy, psychomotor retardation, or cognitive resistance to initiating goal-directed tasks (e.g., Item 5: "I found it difficult to work up the initiative to do things").
• Dysphoric Cognition and Hopelessness: Pervasive cognitive pessimism regarding the future and global negative evaluations of existential purpose (e.g., Item 10: "I felt that I had nothing to look forward to"; Item 21: "I felt that life was meaningless").
• Devaluation of Self-Worth: Core feelings of personal worthlessness and severe self-deprecating cognitive schema (e.g., Item 17: "I felt I wasn't worth much as a person").

Anxiety Subscale

The Anxiety subscale assesses the subjective experience and physiological correlates of an active acute panic response, fear-based autonomic arousal, and skeletal musculature activation. In alignment with neurobiological paradigms of fear circuitry (e.g., sympathetic nervous system arousal), the construct includes:

• Autonomic Nervous System Reactivity: Overt physical manifestations of sympathetic discharge, including xerostomia (dry mouth), respiratory changes, and palpitations (e.g., Item 2: "I was aware of dryness of my mouth"; Item 4: "I experience breathing difficulty"; Item 19: "I was aware of the action of my heart in the absence of physical exertion").
• Skeletal Musculature Effects: Involuntary fine motor tremors and physical agitation associated with acute fright (e.g., Item 7: "I experienced trembling").
• Situational Panic and Cognitive Apprehension: Sudden feelings of terror, panic, or fear of losing behavioral control in social or performance environments (e.g., Item 9: "I was worried about situation in which I might panic and make a fool of myself"; Item 15: "I felt I was close to panic"; Item 20: "I felt scared without any good reason").

Stress Subscale

The Stress subscale captures a prolonged, persistent state of non-specific autonomic tension and hyperarousal. Whereas anxiety relates to acute fear, phobic reactivity, and autonomic panic bursts, stress represents a sustained state of nervous energy, agitation, and low frustration tolerance. Core components include:

• Difficulty Decompressing and Relaxing: Sustained physical and mental tension that impedes physiological recovery (e.g., Item 1: "I found it hard to 'wind down'"; Item 12: "I found it difficult to relax").
• Nervous Hyperarousal and Energy Depletion: Chronic subjective activation and the perception of operating under internal pressure (e.g., Item 8: "I felt that I was using a lot of nervous energy").
• Irritability, Agitation, and Impatience: Proneness to over-reacting to trivial inconveniences and frustration with delays or interruptions (e.g., Item 6: "I tended to over-react to situations"; Item 11: "I found myself getting agitated"; Item 14: "I was intolerant of anything that kept me from getting on with what I was doing"; Item 18: "I felt that I was rather touchy").

6. Theoretical Framework

The conceptual foundation of the DASS-21 is deeply rooted in the empirical and cognitive-behavioral traditions of affective psychology, specifically interfacing with the Tripartite Model of Anxiety and Depression formulated by Lee Anna Clark and David Watson (1991). The tripartite model addressed the widespread diagnostic co-morbidity and psychometric overlap between anxiety and depressive syndromes by decomposing affective disturbances into three structural elements:

1. General Distress / Negative Affectivity (NA): A non-specific factor shared between anxiety and depression, comprising general emotional upset, distress, dysphoria, and neurotic vulnerability.
2. Physiological Hyperarousal (PH): A specific somatic factor unique to anxiety, manifested through autonomic arousal, tachycardia, shortness of breath, trembling, and panic symptoms.
3. Low Positive Affectivity (LPA) / Anhedonia: A specific factor unique to depression, manifested as loss of joy, diminished pleasure, avolition, loss of vitality, and existential despair.

Peter and Syd Lovibond utilized empirical factor analytic methods on patient cohorts to derive scales that isolated these distinct constructs. Their findings revealed that while low positive affect cleanly defines depression and autonomic arousal cleanly defines anxiety, the non-specific "general distress" dimension can be coherently divided into shared variance versus a distinct psychological entity characterized by chronic nervous tension, mental over-arousal, and reduced tolerance for frustration. This distinct entity forms the basis of the DASS Stress dimension.

From an evolutionary and cognitive standpoint, the tripartite architecture of the DASS-21 reflects distinct physiological systems. The Anxiety scale aligns with the immediate survival response (the fight-or-flight response mediated by the amygdala and sympathetic-adrenomedullary axis). The Depression scale reflects behavioral withdrawal, conservation of energy, and anhedonic shutdown mediated by dysregulations in dopaminergic and mesolimbic reward pathways. The Stress scale operationalizes chronic activation of the hypothalamic-pituitary-adrenal (HPA) axis, representing sustained mobilization in response to persistent environmental or internal demands.

7. Validity

The DASS-21 has been subjected to extensive psychometric evaluations across clinical, general adult, adolescent, student, and cross-cultural cohorts worldwide. Across these empirical studies, the scale demonstrates high construct, convergent, and discriminant validity.

Convergent Validity

Convergent validity is established through substantial, statistically significant correlations with other widely validated self-report instruments measuring depressive and anxious symptoms:

• Depression Scale: Studies by Antony et al. (1998) and Crawford and Henry (2003) report that the DASS-21 Depression subscale correlates strongly with the Beck Depression Inventory (BDI/BDI-II), with Pearson coefficients ranging between r = .74 and r = .85. Furthermore, it correlates positively with the Center for Epidemiologic Studies Depression Scale (CES-D) at r = .78.
• Anxiety Scale: The DASS-21 Anxiety subscale correlates strongly with the Beck Anxiety Inventory (BAI), with coefficients ranging from r = .70 to r = .81 (Antony et al., 1998; Lovibond & Lovibond, 1995b). It correlates similarly with the State-Trait Anxiety Inventory (STAI-Trait) at r = .68 to .73.
• Stress Scale: The Stress subscale correlates moderately to strongly with the Perceived Stress Scale (PSS; r = .65 to .74) and with the BAI and BDI (r = .55 to .65), reflecting its character as a bridge between pure anhedonia and acute autonomic fright.

Discriminant Validity

A central advantage of the DASS-21 over legacy instruments is its ability to differentiate pure depressive symptomology from pure somatic panic:

• The correlation between the DASS-21 Depression subscale and the Beck Anxiety Inventory is consistently lower (typically r = .45 to .55) than its correlation with the BDI (r > .75).
• The correlation between the DASS-21 Anxiety subscale and the Beck Depression Inventory is markedly lower (typically r = .40 to .52) than its correlation with the BAI (r > .75).
• When structural equation models are tested, latent factors representing Depression, Anxiety, and Stress maintain discriminant coefficients that show significantly better model fit than single-factor or two-factor models (Brown et al., 1997; Henry & Crawford, 2005).

Predictive and Known-Groups Validity

The scale effectively differentiates between clinical and non-clinical populations. In clinical trials, individuals diagnosed with Major Depressive Disorder (MDD) score significantly higher on the Depression subscale than individuals with Generalized Anxiety Disorder (GAD) or Panic Disorder. Conversely, patients with Panic Disorder score significantly higher on the Anxiety subscale compared to depressed patients without comorbid panic features (Antony et al., 1998; Page et al., 2007).

8. Reliability

The DASS-21 demonstrates exceptional reliability parameters across diverse demographic sectors and international cohorts.

Internal Consistency

Internal consistency metrics, assessed via Cronbach's alpha (α) and McDonald's omega (ω), consistently surpass traditional psychometric benchmarks (≥ .80 for basic research, ≥ .90 for clinical evaluation):

• Depression Subscale: Cronbach's alpha values span from α = .88 to .94 across both non-clinical normative samples (Henry & Crawford, 2005, N = 1,794: α = .88) and clinical psychiatric samples (Antony et al., 1998: α = .94).
• Anxiety Subscale: Cronbach's alpha values range from α = .82 to .87 (Henry & Crawford, 2005: α = .82; Antony et al., 1998: α = .87; Osman et al., 2012: α = .85).
• Stress Subscale: Cronbach's alpha values range from α = .85 to .91 (Henry & Crawford, 2005: α = .90; Antony et al., 1998: α = .91).
• Total Scale: Across all 21 items, overall composite reliability routinely reaches α = .93 to .96.

Test-Retest Reliability

Test-retest stability confirms the temporal reliability of the DASS-21 when evaluated over short-to-medium intervals. Over a two-to-four-week baseline without clinical intervention, test-retest intraclass correlation coefficients (ICCs) range between .71 and .83 (Lovibond & Lovibond, 1995a). Because the scale explicitly prompts symptom frequency "over the past week," moderate stability reflects expected temporal fluctuations in affective states while confirming that the underlying traits remain structurally stable.

9. Factor Analysis

The latent dimensionality of the DASS-21 has been rigorously analyzed via both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) across tens of thousands of participants globally.

Exploratory Factor Analysis (EFA)

In early validation studies (Lovibond & Lovibond, 1995a; Antony et al., 1998), principal axes factor analyses with oblique or varimax rotation reliably identified three dominant eigenvalues exceeding unity. All items displayed robust primary factor loadings (typically ranging from .50 to .82) on their respective designated factors (Depression, Anxiety, or Stress), with cross-loadings rarely exceeding .30. These empirical findings supported the structural distinction among autonomic panic (Anxiety), chronic tension (Stress), and anhedonic dysphoria (Depression).

Confirmatory Factor Analysis (CFA)

Researchers have evaluated several competing structural models using CFA:

• One-Factor Model: Assumes all 21 items reflect a single unidimensional construct of generalized psychological distress or negative affectivity. This model exhibits unacceptable fit indices (e.g., χ²/df > 8.0, CFI < .80, RMSEA > .10).
• Two-Factor Model: Combines Anxiety and Stress items into an overarching emotional tension/anxiety factor contrasted against Depression. While superior to the unidimensional model, it falls below recommended thresholds for acceptable fit.
• Three-Factor Tripartite Model: Hypothesizes three correlated latent factors: Depression, Anxiety, and Stress. This model yields strong fit indices across diverse cohorts (Henry & Crawford, 2005: Comparative Fit Index [CFI] = .94 to .96, Tucker-Lewis Index [TLI] = .93 to .95, Root Mean Square Error of Approximation [RMSEA] = .044 to .052).
• Bifactor Model: Incorporates a general distress factor ("g-factor") alongside three orthogonal, specific group factors for Depression, Anxiety, and Stress. Research by Osman et al. (2012) and Henry & Crawford (2005) indicated that the bifactor model frequently achieves excellent statistical fit (CFI > .97, RMSEA < .04). This supports the clinical practice of reporting both individual subscale scores and a total psychological distress score.

10. Instrument / Measurement Tool

The operational specifications of the DASS-21 instrument are summarized below:

• Test Type: Self-administered psychological assessment / self-report psychometric rating scale.
• Format: Available in paper-and-pencil, computerized, and mobile clinical administration formats.
• Number of Items: 21 items (7 items per subscale: Depression, Anxiety, Stress).
• Administration Time: Approximately 3 to 5 minutes.
• Response Scale: 4-point Likert-type severity/frequency rating scale:
• 0: Did not apply to me at all
• 1: Applied to me to some degree or for some of time
• 2: Applied to me to consider degree or for a good part of time
• 3: Applied to me very much or most of the time
• Target Population: Adults, university students, and adolescents aged 14 and older.
• Recall Period: Past 7 days ("over the past week").
• Subscale Item Breakdown:
  • Depression: Items 3, 5, 10, 13, 16, 17, 21.
  • Anxiety: Items 2, 4, 7, 9, 15, 19, 20.
  • Stress: Items 1, 6, 8, 11, 12, 14, 18.
• Scoring and Transformation Rules:
  • Raw scores for each subscale are calculated by summing the 7 respective items (possible raw score range: 0 to 21 per subscale).
  • To compare DASS-21 scores with the full 42-item DASS normative data and clinical severity cutoffs, each subscale raw score is multiplied by 2 (resulting in a transformed range of 0 to 42 per subscale).
  • A Total Distress score can also be calculated by summing all 21 items and multiplying by 2 (range 0 to 126).
• Clinical Severity Cut-Off Scores (Multiplied ×2 Scale):
  • Depression: Normal (0–9), Mild (10–13), Moderate (14–20), Severe (21–27), Extremely Severe (28+).
  • Anxiety: Normal (0–7), Mild (8–9), Moderate (10–14), Severe (15–19), Extremely Severe (20+).
  • Stress: Normal (0–14), Mild (15–18), Moderate (19–25), Severe (26–33), Extremely Severe (34+).

11. Permissions & Fee and Test Year

The Depression, Anxiety and Stress Scales were originally published in 1995. The Lovibond group at the University of New South Wales made the instrument public domain for educational, clinical, and non-commercial research purposes:

• Test Year: 1995 (original manual and validation papers published by Syd H. Lovibond and Peter F. Lovibond).
• Permissions and Access: The DASS-21 is open-access and may be used without explicit individual written permission or user fees by clinicians, academics, and students, provided that the authors and the University of New South Wales are credited appropriately.
• Commercial Use: Incorporation of the DASS-21 into commercial software platforms, for-profit electronic medical record systems, or clinical trial operations for commercial drug development may require explicit licensing agreements. Official documentation and normative scales are hosted on the official UNSW DASS website.

12. References

• Antony, M. M., Bieling, P. J., Cox, B. J., Enns, M. W., & Swinson, R. P. (1998). Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. Psychological Assessment, 10(2), 176–181. https://doi.org/10.1037/1040-3590.10.2.176
• Brown, T. A., Chorpita, B. F., Korotitsch, W., & Barlow, D. H. (1997). Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behaviour Research and Therapy, 35(1), 79–89. https://doi.org/10.1016/S0005-7967(96)00068-X
• Clark, L. A., & Watson, D. (1991). Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. Journal of Abnormal Psychology, 100(3), 316–336. https://doi.org/10.1037/0021-843X.100.3.316
• Crawford, J. R., & Henry, J. D. (2003). The Depression Anxiety Stress Scales (DASS): Normative data and latent structure in a large non-clinical sample. British Journal of Clinical Psychology, 42(2), 111–131. https://doi.org/10.1348/014466503321903544
• Henry, J. D., & Crawford, J. R. (2005). The short-form version of the Depression Anxiety Stress Scales (DASS-21): Construct validity and normative data in a large non-clinical sample. British Journal of Clinical Psychology, 44(2), 227–239. https://doi.org/10.1348/014466505X29657
• Lovibond, P. F., & Lovibond, S. H. (1995a). The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behaviour Research and Therapy, 33(3), 335–343. https://doi.org/10.1016/0005-7967(94)00075-U
• Lovibond, S. H., & Lovibond, P. F. (1995b). Manual for the Depression Anxiety Stress Scales (2nd ed.). Psychology Foundation of Australia.
• Norton, P. J. (2007). Depression Anxiety and Stress Scales (DASS-21): Psychometric analysis across four racial groups. Anxiety, Stress, & Coping, 20(3), 253–265. https://doi.org/10.1080/10615800701309279
• Osman, A., Wong, J. L., Bagge, C. L., Feldner, M., Yanakieva, S., & Lozano, G. (2012). The Depression Anxiety Stress Scales-21 (DASS-21): Further examination of dimensions, scale reliability, and correlates. Journal of Clinical Psychology, 68(12), 1322–1338. https://doi.org/10.1002/jclp.21908
• Page, A. C., Hooke, G. R., & Morrison, D. L. (2007). Psychometric properties of the Depression Anxiety Stress Scales (DASS) in depressed clinical samples. British Journal of Clinical Psychology, 46(3), 283–297. https://doi.org/10.1348/014466506X158996

13. Items of the Scale (Questionnaire)